Literature DB >> 10327381

A possible dopaminergic mechanism in the serotonergic antidepressant-induced sexual dysfunctions.

A G Alcántara1.   

Abstract

The administration of antidepressant serotoninergic medication is associated with the presentation of sexual dysfunctions. This seems to be mediated by the activation of the 5-HT2 receptors. Segraves (1995) has proposed that the inhibition of noradrenergic transmission by serotonin may be the mechanism which causes the antidepressant-induced sexual dysfunctions. The inhibition which the 5-HT2 receptors carry out on dopaminergic transmission leads us to propose this mechanism as also participating in the antidepressant-induced sexual dysfunctions.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10327381     DOI: 10.1080/00926239908403985

Source DB:  PubMed          Journal:  J Sex Marital Ther        ISSN: 0092-623X


  3 in total

Review 1.  Female sexual dysfunction: potential for pharmacotherapy.

Authors:  Jean L Fourcroy
Journal:  Drugs       Date:  2003       Impact factor: 9.546

2.  Antidepressant-associated sexual dysfunction: impact, effects, and treatment.

Authors:  Agnes Higgins; Michael Nash; Aileen M Lynch
Journal:  Drug Healthc Patient Saf       Date:  2010-09-09

3.  Efficacy and tolerability of vilazodone for major depressive disorder: evidence from phase III/IV randomized controlled trials.

Authors:  Ligen Shi; Jingyi Wang; Shenbin Xu; Yunrong Lu
Journal:  Drug Des Devel Ther       Date:  2016-11-25       Impact factor: 4.162

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.